PPP1CB (Protein Phosphatase 1 Beta) encodes the beta isoform of protein phosphatase 1 (PP1), a major serine/threonine phosphatase that plays critical roles in regulating numerous cellular processes including glycogen metabolism, muscle contraction, synaptic plasticity, and cell division. PP1 is one of the most important phosphatases in the brain, where it regulates phosphorylation of proteins implicated in neurodegenerative diseases.
| Symbol | PPP1CB |
| Full Name | Protein Phosphatase 1 Catalytic Subunit Beta |
| Aliases | PP1β, PP1B |
| Chromosomal Location | Chromosome 2p23.3 |
| NCBI Gene ID | 5500 |
| OMIM | 176914 |
| Ensembl ID | ENSG00000185630 |
| UniProt ID | P62140 |
| Protein Class | Serine/Threonine Phosphatase |
¶ Protein Structure and Function
- EC Number: 3.1.3.16
- Family: Protein phosphatase type 1 family
- Structure: Catalytic subunit (~37 kDa)
PP1CB catalyzes the removal of phosphate groups from serine and threonine residues. The enzyme requires metal ions (typically Mn2+ or Mg2+) for catalytic activity and is regulated by:
- Subunit composition: PP1 exists as a heterotrimeric complex with targeting subunits
- Post-translational modifications: Phosphorylation, oxidation, and nitrosylation
- Inhibitor proteins: CPI-17, DARPP-32, Inhibitor-1, Inhibitor-2
PP1CB dephosphorylates numerous substrates relevant to neurodegeneration:
- Tau protein: Dephosphorylation at multiple AD-relevant sites (Ser202, Thr231, Ser396)
- Glycogen synthase: Regulation of glycogen metabolism
- Synaptic proteins: Synapsin, PSD-95, AMPA receptor subunits
- Transcription factors: CREB, c-Jun
- Tau pathology: PP1-mediated tau dephosphorylation is a key mechanism for reducing tau aggregation and toxicity
- Synaptic plasticity: PP1 regulates long-term depression (LTD) and memory consolidation
- Amyloid-β effects: Aβ exposure can alter PP1 activity and distribution
- Therapeutic targeting: PP1 activators are being investigated as AD therapeutics
- α-Synuclein phosphorylation: PP1 may regulate kinases that phosphorylate α-synuclein at Ser129
- Dopaminergic signaling: PP1 modulates DARPP-32 signaling in striatal neurons
- Mitochondrial function: PP1 regulates mitochondrial dynamics proteins
- TDP-43 pathology: PP1 activity influences TDP-43 phosphorylation status
- Motor neuron survival: PP1-mediated signaling pathways affect motor neuron viability
- Huntingtin phosphorylation: PP1 can dephosphorylate mutant huntingtin
- Transcription regulation: PP1 modulates transcription factors affected in HD
¶ Brain Expression and Localization
PPP1CB is widely expressed throughout the brain:
- Cerebral cortex: High expression in pyramidal neurons
- Hippocampus: CA1-CA3 regions and dentate gyrus
- Basal ganglia: Striatum (medium spiny neurons)
- Cerebellum: Purkinje cells
- Cytosolic: General phosphatase activity
- Synaptic fraction: Regulates synaptic plasticity
- Nuclear: Transcriptional regulation
- Mitochondria: Metabolic regulation
- PP1 activators: Increase tau dephosphorylation
- Selective targeting: Isoform-specific modulators
- Substrate-directed inhibitors: For specific disease contexts
- PP1 activity levels in cerebrospinal fluid (CSF) may serve as biomarkers
- Post-mortem brain tissue shows altered PP1 in AD and PD